Neurocrine Biosciences Inc. Earnings

Neurocrine Biosciences Inc.’s revenue jumped 16.49% since last year same period to $687.5Mn in the Q2 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 20.07% jump in its revenue since last 3-months.

Neurocrine Biosciences Inc.’s net profit jumped 65.38% since last year same period to $107.5Mn in the Q2 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 1260.76% jump in its net profits since last 3-months.

Neurocrine Biosciences Inc.’s net profit margin jumped 41.98% since last year same period to 15.64% in the Q2 2025. On a quarterly growth basis, Neurocrine Biosciences Inc. has generated 1033.34% jump in its net profit margins since last 3-months.

Neurocrine Biosciences Inc.’s price-to-earnings ratio after this Q2 2025 earnings stands at 40.49.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.56 - a 59.44% jump from last quarter’s estimates.

Neurocrine Biosciences Inc.’s earning per share (EPS) estimates for the current year stand at 1.56.

Neurocrine Biosciences Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Neurocrine Biosciences Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.